Vaxart, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Vaxart, Inc. (VXRT) had Lessee, Operating Lease, Liability, to be Paid, Year Five of $1.35 million as of 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2025-03-20
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $1.35M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.39M.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.39M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $5.14M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2024-12-31 | $1.35M 10-K · filed 2025-03-20 |
| 2023-12-31 | $5.39M 10-K · filed 2024-03-14 |
| 2023-09-30 | $5.39M 10-Q · filed 2023-11-02 |
| 2022-12-31 | $5.14M 10-K · filed 2023-03-15 |
| 2021-12-31 | $2.85M 10-K · filed 2022-02-24 |
| 2020-12-31 | $1.11M 10-K · filed 2021-02-25 |
| 2020-03-31 | $360.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $360.00K 10-K · filed 2020-03-19 |
| 2019-09-30 | $348.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |